Use of Predictive Analytics to Identify Unhealthy Opioid Use and Guide Intervention.
Autor: | Valdes EG; Relias, Morrisville, North Carolina (Valdes, Reist, Aamar, Gorman); MindX Sciences, Indianapolis (Reist); Eastpointe Human Services, Beulaville, North Carolina (Hallisey); Partners Health Management, Gastonia, North Carolina (Stanton, Williams); Edson College of Nursing and Health Innovation, Arizona State University, Phoenix (Andel)., Reist C; Relias, Morrisville, North Carolina (Valdes, Reist, Aamar, Gorman); MindX Sciences, Indianapolis (Reist); Eastpointe Human Services, Beulaville, North Carolina (Hallisey); Partners Health Management, Gastonia, North Carolina (Stanton, Williams); Edson College of Nursing and Health Innovation, Arizona State University, Phoenix (Andel)., Aamar R; Relias, Morrisville, North Carolina (Valdes, Reist, Aamar, Gorman); MindX Sciences, Indianapolis (Reist); Eastpointe Human Services, Beulaville, North Carolina (Hallisey); Partners Health Management, Gastonia, North Carolina (Stanton, Williams); Edson College of Nursing and Health Innovation, Arizona State University, Phoenix (Andel)., Hallisey B; Relias, Morrisville, North Carolina (Valdes, Reist, Aamar, Gorman); MindX Sciences, Indianapolis (Reist); Eastpointe Human Services, Beulaville, North Carolina (Hallisey); Partners Health Management, Gastonia, North Carolina (Stanton, Williams); Edson College of Nursing and Health Innovation, Arizona State University, Phoenix (Andel)., Stanton ES; Relias, Morrisville, North Carolina (Valdes, Reist, Aamar, Gorman); MindX Sciences, Indianapolis (Reist); Eastpointe Human Services, Beulaville, North Carolina (Hallisey); Partners Health Management, Gastonia, North Carolina (Stanton, Williams); Edson College of Nursing and Health Innovation, Arizona State University, Phoenix (Andel)., Williams L; Relias, Morrisville, North Carolina (Valdes, Reist, Aamar, Gorman); MindX Sciences, Indianapolis (Reist); Eastpointe Human Services, Beulaville, North Carolina (Hallisey); Partners Health Management, Gastonia, North Carolina (Stanton, Williams); Edson College of Nursing and Health Innovation, Arizona State University, Phoenix (Andel)., Andel R; Relias, Morrisville, North Carolina (Valdes, Reist, Aamar, Gorman); MindX Sciences, Indianapolis (Reist); Eastpointe Human Services, Beulaville, North Carolina (Hallisey); Partners Health Management, Gastonia, North Carolina (Stanton, Williams); Edson College of Nursing and Health Innovation, Arizona State University, Phoenix (Andel)., Gorman J; Relias, Morrisville, North Carolina (Valdes, Reist, Aamar, Gorman); MindX Sciences, Indianapolis (Reist); Eastpointe Human Services, Beulaville, North Carolina (Hallisey); Partners Health Management, Gastonia, North Carolina (Stanton, Williams); Edson College of Nursing and Health Innovation, Arizona State University, Phoenix (Andel). |
---|---|
Jazyk: | angličtina |
Zdroj: | Psychiatric services (Washington, D.C.) [Psychiatr Serv] 2023 Jun 01; Vol. 74 (6), pp. 622-627. Date of Electronic Publication: 2022 Dec 22. |
DOI: | 10.1176/appi.ps.202200034 |
Abstrakt: | Objective: The authors aimed to use the newly developed Opioid Risk Stratification Tool to identify individuals who may be at risk for unhealthy opioid use and to examine the impact of applying a mailing and engagement intervention to this population and their prescribers, with the goal of reducing high-risk prescribing behaviors, opioid medication use, and mortality rates. Methods: A nonrandomized controlled study was conducted with members from two Medicaid managed care organizations. In both the intervention (N=131) and control (N=187) groups, an algorithm identified members at moderate to high risk for hazardous opioid use. Members at increased risk in the intervention group and their prescribers received a letter from the managed care organization, and members still at risk 3 months after the mailing were contacted by a care coordinator. Individuals in the control group were not contacted. Medicaid claims data were used to compare opioid use and prescribing practices between groups before and after the intervention. Results: Individuals in the intervention group were less likely to have any opioid prescription postintervention compared with those in the control group (OR=0.55, p<0.001), and the intervention group had a greater reduction in the number of individuals with concurrent opioid and benzodiazepine prescriptions (OR=0.49, p=0.042). Practices such as multiple opioid prescriptions and multiple prescribers of opioids were not affected by the intervention. Conclusions: An intervention targeting individuals at risk for hazardous opioid use was associated with a reduction in some high-risk prescribing practices. Future research should determine the ideal mix of interventions to reduce as many risk factors as possible. Competing Interests: Drs. Valdes and Aamar are employed by Relias, the company that created the Opioid Risk Stratification Tool. Drs. Reist and Gorman are consultants to Relias. At the time of the study, Ms. Hallisey was employed by Partners Health Management. Dr. Gorman receives royalties from Oxford University Press. The other authors report no financial relationships with commercial interests. |
Databáze: | MEDLINE |
Externí odkaz: |